Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Multi-omics endotype of preterm infants with bronchopulmonary dysplasia and pulmonary hypertension

View ORCID ProfileRoopa Siddaiah, Christiana Oji-Mmuo, Vincent Aluquin, Yuka Imamura Kawasawa, Ann Donnelly, Dustin Rousselle, Nathalie Fuentes, Eric D. Austin, Patricia Silveyra
doi: https://doi.org/10.1101/2022.11.03.22281890
Roopa Siddaiah
1Department of Pediatrics, Penn State Health Children’s Hospital, Hershey, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Roopa Siddaiah
  • For correspondence: rsiddaiah@pennstatehealth.psu.edu
Christiana Oji-Mmuo
1Department of Pediatrics, Penn State Health Children’s Hospital, Hershey, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Vincent Aluquin
1Department of Pediatrics, Penn State Health Children’s Hospital, Hershey, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuka Imamura Kawasawa
2Department of Pharmacology, Penn State Health Children’s Hospital, Hershey, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ann Donnelly
3Department of Respiratory Therapy, Penn State Health Children’s Hospital, Hershey, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dustin Rousselle
4Department of Environmental and Occupational Health, Indiana University School of Public Health, Bloomington, IN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nathalie Fuentes
1Department of Pediatrics, Penn State Health Children’s Hospital, Hershey, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric D. Austin
5Department of Pediatrics, Vanderbilt University, Vanderbilt, TN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patricia Silveyra
1Department of Pediatrics, Penn State Health Children’s Hospital, Hershey, PA
4Department of Environmental and Occupational Health, Indiana University School of Public Health, Bloomington, IN
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Rationale Pulmonary hypertension associated with bronchopulmonary dysplasia is a severe complication of preterm birth resulting in high mortality of up to 50% within the first 2 years of life. There is a direct relationship between bronchopulmonary dysplasia severity and incidence of associated pulmonary hypertension. However, it is challenging to clinically characterize severe bronchopulmonary dysplasia with and without pulmonary hypertension and there is need for better understanding of the two entities.

Objectives To identify markers to help understand biological processes and endotype characterization of infants with pulmonary hypertension associated with bronchopulmonary dysplasia in tracheal aspirates.

Methods We conducted multi-omic analysis of tracheal aspirates via miRNA PCR arrays, RNA sequencing and mass spectrometry proteomics in preterm infants with severe bronchopulmonary dysplasia with (n=21) and without (n=25) pulmonary hypertension.

Results Our study analysis revealed 12 miRNAs (hsa-miR-29a, has-miR-542-3p, has-miR-624, has-miR-183, hsa-miR-501-3p, hsa-miR-101, hsa-miR-3131, hsa-miR-3683, hsa-miR-3193, hsa-miR-3672, hsa-miR-3128, and hsa-miR-1287); 6 transcripts (IL6, RPL35P5, HSD3B7, RNA5SP215, OR2A1-AS1, and RNVU1-19), and 5 proteins (CAPS, AAT, KRT5, SFTPB, and LGALS3BP) with significant differential expression in preterm infants with severe lung disease with pulmonary hypertension when compared to infants with severe lung disease but no pulmonary hypertension. Pathway analysis of the integrated multi-omic expression signatures revealed NFkB, VEGF, SERPINA1, IL6 and ERK12 as target molecules for miRNAs, and angiogenesis and hyperoxia stress as recurrent pathways of individual markers.

Conclusion Our multi-omic analysis of tracheal aspirates revealed a comprehensive thumbprint of miRNAs, mRNAs and proteins that could help endotype infants with severe lung disease and pulmonary hypertension.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Center for Research on Women and Newborn Health; Childrens Miracle Network; Department of Pediatrics Startup funding; Penn State Health Core facility laboratory

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Penn State Health institutional review board (STUDY 00000482) gave ethical approval for this work

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Funding source: Center for Research on Women and Newborn Health; Children’s Miracle Network, Department of Pediatrics Startup funding, Penn State Health Core facility laboratory.

Data Availability

All data produced in the present work are contained in the manuscript as links to online repository

https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE205138

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 05, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Multi-omics endotype of preterm infants with bronchopulmonary dysplasia and pulmonary hypertension
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Multi-omics endotype of preterm infants with bronchopulmonary dysplasia and pulmonary hypertension
Roopa Siddaiah, Christiana Oji-Mmuo, Vincent Aluquin, Yuka Imamura Kawasawa, Ann Donnelly, Dustin Rousselle, Nathalie Fuentes, Eric D. Austin, Patricia Silveyra
medRxiv 2022.11.03.22281890; doi: https://doi.org/10.1101/2022.11.03.22281890
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Multi-omics endotype of preterm infants with bronchopulmonary dysplasia and pulmonary hypertension
Roopa Siddaiah, Christiana Oji-Mmuo, Vincent Aluquin, Yuka Imamura Kawasawa, Ann Donnelly, Dustin Rousselle, Nathalie Fuentes, Eric D. Austin, Patricia Silveyra
medRxiv 2022.11.03.22281890; doi: https://doi.org/10.1101/2022.11.03.22281890

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pediatrics
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1093)
  • Dentistry and Oral Medicine (195)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
  • Epidemiology (9757)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2303)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1553)
  • Health Policy (732)
  • Health Systems and Quality Improvement (602)
  • Hematology (236)
  • HIV/AIDS (501)
  • Infectious Diseases (except HIV/AIDS) (11631)
  • Intensive Care and Critical Care Medicine (616)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (256)
  • Neurology (2139)
  • Nursing (134)
  • Nutrition (335)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1172)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (309)
  • Pediatrics (694)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2172)
  • Public and Global Health (4645)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (455)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (208)
  • Surgery (250)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)